Diwali Muhurat Picks
Dynamic View
Stock Picks
IPO
Rakesh Jhunjhunwala
Reading -NRI
Broker Research
Search & Popular Tags
18 April 2011
IFCI research, News Update, 15 Apr, 2011
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Morning News (click on link to read article)
Economic Times
Business Standard
Ø
WMA cap breached in first week itself
Ø
Satyam auditing not the only slip-up in india, admits Price Waterhouse India
Ø
RBI, Sebi likely to crack the whip on FII funds in banks
Ø
Consumer durables, banks to gain from India growth
Ø
Orissa plans to seek ban on iron ore export
Ø
India wants World Bank to raise lending limits
Ø
SBI to make loans dearer, others to follow suit
Ø
Tatas plan Rs 1.2-lakh-cr investments in India
Ø
Sterlite to double copper-smelting plant in Tuticorin
Ø
Africa hot favourite among Guj pharma firms
Ø
Kernex Microsystems eyes Thailand, Bangladesh railways
Ø
Soaring input costs keep realty prices up
Business Line
Ø
Promoters, large investors make big money from dividends
Ø
NTC to build on closed mill space in Mumbai
Ø
Patel hopeful of Air India bail out plan
Ø
Knitwear industry wants to resolve issues early
Ø
Global recovery vulnerable to debt, commodities: IMF
Mint
Ø
Central bank rebuffs SBI on home loans
Ø
TCS takes over Infosys mantle of technology bellwether
Ø
Maharashtra gives priority to industry over agriculture
Ø
Tata Motors cuts production of passenger cars
Ø
China raises bank reserves by 50bps
Financial Express
Ø
Assets under Gold ETFs up 3-fold
Ø
Domestic wine industry grows 300%
Ø
Mukesh Ambani plans big for financial biz
Ø
4G rollout likely by next year: Industry
Ø
Aditya Birla to acquire Kanoria division
Ø
India signs landmark Kazakh oil deal
DNA
Ø
India’s chemical exports will double in 18 months
Ø
‘Short-term debt funds focused on corporate paper will perform’
Ø
Domestic markets stay below downward sloping trendline
Ø
Rupee could come under pressure if risk appetite continues to weaken
Ø
Institutions slice stake in BSE 500 firms in January-March
Ø
‘The valuations MNCs are paying for Indian pharma are absolutely unrealistic’
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment